nuts, I was actually referring to the newspaper article. But, page 6 of Nomura's report states:
http://www.primabiomed.com.au/investor/analyst_reports_pdf/111102_nomura_initiantion.pdf
"• C-Vac has to get through Phase III trials: There is no guarantee that Phase II trials
will lead to positive Phase III trials. We note that the Phase II trial has not demonstrated
statistically significant results so far. Hence, the Phase III clinical trial will assess
statistical significance of the response to C-Vac;"
_______________________________
The Principal Investigator only gave a statistic when comparing patients (those that showed a response compared to those that didn't). He ommitted a statistic for whether the therapeutic was working in a statistically significant way (eg. reduction in tumor size) compared to the no-treatment group's reduction in tumor size.
Like I said, I don't follow this company and am not familiar with the perameters of their clinical trials, and unless you have a background in statistics, reading research reports and clinical data can be somewhat confusing.
I wish Prima and their shareholders every success, just be careful when reading company statements. They are all the same. They highlight the positive early on, but omit the negative until absolutely necessary.
- Forums
- ASX - By Stock
- who is this guy?
nuts, I was actually referring to the newspaper article. But,...
-
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
40.0¢ |
Change
-0.005(1.23%) |
Mkt cap ! $581.0M |
Open | High | Low | Value | Volume |
41.0¢ | 41.5¢ | 39.5¢ | $1.576M | 3.906M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2506 | 39.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
40.0¢ | 8079 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 62000 | 0.390 |
4 | 33064 | 0.385 |
8 | 91570 | 0.380 |
1 | 100000 | 0.370 |
4 | 24220 | 0.360 |
Price($) | Vol. | No. |
---|---|---|
0.410 | 41895 | 3 |
0.415 | 130388 | 7 |
0.420 | 550003 | 10 |
0.425 | 39700 | 3 |
0.430 | 13701 | 3 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online